期刊文献+

组蛋白去乙酰化酶8对肾性高血压大鼠心肌肥大的影响 被引量:7

Role of histone deacetylase 8 in cardiac hypertrophy in two-kidney two-clip renovascular hypertensive rats
下载PDF
导出
摘要 目的:研究组蛋白去乙酰化酶8(histone deacetylase 8,HDAC8)在肾性高血压大鼠左心室肥厚中的表达变化及HDAC抑制剂丙戊酸钠(valproic acid sodium,VPA)对心肌肥厚的影响。方法:建立2肾2夹肾性高血压大鼠模型,术后4周开始给药,VPA高剂量(400 mg.kg-1.d-1)组及VPA低剂量(200 mg.kg-1.d-1)组连续腹腔注射VPA给药4周,同时设立假手术组和阳性对照坎地沙坦(10 mg.kg-1.d-1)组,实验结束时测量左心室/体重比值,HE染色检测心肌组织形态学变化,RT-PCR检测心房利钠因子(atrial natriuretic factor,ANF)和HDAC8mRNA表达,Western blotting检测HDAC8的表达情况。结果:HDAC8 mRNA和蛋白表达水平在肾性高血压大鼠心肌组织中明显上调;VPA能够剂量依赖性降低HDAC8的表达,同时VPA治疗组与坎地沙坦组高血压大鼠的左心室肥厚得到明显逆转,表现为心室体重比降低,肥大心肌形态明显改善且ANF的表达下调。结论:HDAC8参与了肾性高血压大鼠心肌肥厚的发病过程,VPA可以下调其表达并部分逆转心肌肥厚。 AIM: To investigate the expression and the role of histone deacetylase 8(HDAC8) in cardiac hypertrophy and the effects of valproic acid sodium(VPA,a histone deacetylase inhibitor) on the expression of HDAC8 and cardiac hypertrophy in two-kidney two-clip(2K2C) renovascular hypertensive rats.METHODS: Male SD rats were randomly divided into sham operation group,2K2C group,high dose VPA(400 mg·kg-1·d-1) treatment group,low dose VPA(200 mg·kg-1·d-1) treatment group and candesartan(10 mg·kg-1·d-1) treatment group.Four weeks after surgery,the rats were intraperitoneally injected with VPA for 4 weeks.Sham operation and 2K2C rats were given vehicle for 4 weeks.All animals were sacrificed 8 weeks after surgery.The ratio of left ventricular weight to body weight(LVW/BW) was calculated and pathological changes of the myocardium were observed with HE staining.The mRNA expression of atrial natriuretic factor(ANF) and HDAC8 was examined by RT-PCR.The protein level of HDAC8 was also measured by Western blotting analysis.RESULTS: Compared with the control rats,the mRNA and protein expression of HDAC8 significantly increased in the myocardium in 2K2C rats while the mRNA and protein expression of HDAC8 was significantly decreased by VPA treatment in 2K2C rats.The mass index(as measured by LVW/BW) and cardiomyocyte cross areas were markedly increased and myocardial fibers were disordered in 2K2C rats,but these parameters were markedly reversed after treated with VPA for 4 weeks,indicating that VPA attenuated cardiac hypertrophy.Moreover,VPA also decreased the mRNA expression of ANF.CONCLUSION: HDAC8 may play an important role in cardiac hypertrophy in 2K2C renovascular hypertensive rats.VPA inhibits the expression of HDAC8 and prevents the development of cardiac hypertrophy.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第2期253-257,共5页 Chinese Journal of Pathophysiology
关键词 组蛋白去乙酰化酶8 高血压 肾性 左心室肥大 丙戊酸钠 大鼠 Histone deacetylase 8 Hypertension renal Left ventricular hypertrophy Valproic acid sodium Rats
  • 相关文献

参考文献11

  • 1Gallo P,Latronico MV,Gallo P,et al.Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure[J].Cardiovasc Res,2008,80(3):416-424.
  • 2李瑞芳,乐康,高洁,杨国庆,鲍颖霞,刘培庆.抑制PPAR-α表达对ET-1诱导的心肌肥大和PI3K/Akt/GSK3β-NFATc4通路的影响[J].中国病理生理杂志,2009,25(12):2289-2294. 被引量:10
  • 3Nasrin N,Kaushik VK,Fortier E,et al.JNK1 phosphorylates SIRT1 and promotes its enzymic activity[J].PLoS One,2009,4(12):e8414.
  • 4Kee HJ,Kook H.Roles and targets of class Ⅰand Ⅱa histone deacetylases in cardiac hypertrophy[J].J Biomed Biotechnol,2011,2011:928326.
  • 5曹珊珊,李瑞芳,方伟进,李艳,王建刚,杜景霞,黄国辉.肾性高血压大鼠模型制作的改良方法[J].河南科技大学学报(医学版),2010,28(3):165-167. 被引量:10
  • 6席玉慧,孟庆威,徐长庆,王丽娜,林岩,李鸿珠,张力.Sirt1参与异丙肾上腺素诱导的小鼠心肌肥大[J].中国病理生理杂志,2010,26(5):844-847. 被引量:4
  • 7Ago T,Liu T,Zhai P,et al.A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy[J].Cell,2008,133(6):978-993.
  • 8Cho YK,Eom GH,Kee HJ,et al.Sodium valproate,a histone deacetylase inhibitor but not captopril prevents right ventricular hypertrophy in rats[J].Circ J,2010,74(4):760-770.
  • 9Kee HJ,Sohn IS,Nam KI,et al.Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding[J].Circulation,2006,113(1):51-59.
  • 10Lu Y,Yang S.AngiotensinⅡinduces cardiomyocyte hypertrophy probably through histone deacetylases[J].Tohoku J Exp Med,2009,219(1):17 -23.

二级参考文献28

  • 1杜文娟,于波,陆莹.组蛋白脱乙酰基酶2在大鼠心肌肥大中的作用[J].中国地方病学杂志,2005,24(6):600-603. 被引量:4
  • 2王东,蒋湘莲,聂亚雄.高血压大鼠模型的研究进展[J].中国动脉硬化杂志,2006,14(3):271-273. 被引量:32
  • 3Irukayama- Tomobe Y, Miyauchi T, Sakai S, et al. Endothelin - 1 - induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator - activated receptor α partly via blockade of c - jun NH2 terminal kinase pathway [J]. Circulation, 2004,109(7) : 904 -910.
  • 4Varet J, Vincent L, Mirshahi P, et al. Fenofibrate inhibits angiogenesis in vitro and in vivo [ J ].Cell Mol Life Sci, 2003,60(4): 810-819.
  • 5Goetze S, Eilers F, Bungenstock A, et al. PPAR activators inhibit endothelial cell migration by targeting Akt[ J]. Biochem Biophys Res Commun, 2002, 293 (5) : 1431 - 1437.
  • 6Markou T, Cullingford TE, Giraldo A, et al. Glycogen synthase kinases 3 alpha and 3 beta in cardiac myocytes: regulation and consequences of their inhibition [ J ]. Cell Signal, 2008, 20 ( 1 ) : 206 - 218.
  • 7Hardt SE, Sadoshima J. Negative regulators of cardiac hypertrophy [ J ].Cardiovasc Res, 2004,63 (3) : 500 - 509.
  • 8van Rooij E, Doevendans PA, de Theije CC, et al. Requirement of nuclear factor of activated T - ceils in calci- neurin - mediated cardiomyocyte hypertrophy [ J ]. J Biol Chem, 2002, 277(50): 48617-48626.
  • 9Li R, Zheng W, Pi R, et al. Activation of peroxisome proliferator- activated receptor- alpha prevents glycogen synthase 3 beta phosphorylation and inhibits cardiac hypertrophy[J]. FEBS Lett, 2007, 581(17) : 3311 -3316.
  • 10Kerkela R, Kockeritz L, Macaulay K, et al. Deletion of GSK- 3 beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation [ J ]. J Clin Invest, 2008, 118(11): 3609-3618.

共引文献21

同被引文献93

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部